We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$191M
AUM Growth
+$8.08M
Cap. Flow
-$2.26M
Cap. Flow %
-1.18%
Top 10 Hldgs %
44.61%
Holding
206
New
11
Increased
19
Reduced
32
Closed
5

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.95M
2
QCOM icon
Qualcomm
QCOM
+$1.31M
3
GE icon
GE Aerospace
GE
+$922K
4
SLB icon
SLB Ltd
SLB
+$795K
5
AAPL icon
Apple
AAPL
+$566K

Sector Composition

Rank Sector Weight
1 Technology 21.56%
2 Financials 14.93%
3 Energy 13.11%
4 Healthcare 11.29%
5 Communication Services 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
51
Visa
V
$684B
$324K 0.17%
2,162
BKNG icon
52
Booking.com
BKNG
$149B
$282K 0.15%
3,550
-250
-7% -$19.7K
PFE icon
53
Pfizer
PFE
$143B
$276K 0.14%
6,613
GILD icon
54
Gilead Sciences
GILD
$162B
$274K 0.14%
3,550
DSI icon
55
iShares MSCI KLD 400 Social ETF
DSI
$5.3B
$267K 0.14%
4,992
VCIT icon
56
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$259K 0.14%
3,100
-100
-3% -$8.38K
T icon
57
AT&T
T
$159B
$245K 0.13%
9,660
BNY
58
Bank of New York Mellon
BNY
$106B
$227K 0.12%
4,450
+400
+10% +$21K
HRL icon
59
Hormel Foods
HRL
$13.8B
$221K 0.12%
5,600
CX icon
60
Cemex
CX
$17.1B
$219K 0.11%
31,067
SCHZ icon
61
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$196K 0.1%
7,820
XBI icon
62
State Street SPDR S&P Biotech ETF
XBI
$9.6B
$190K 0.1%
1,980
PEP icon
63
PepsiCo
PEP
$190B
$173K 0.09%
1,550
VZ icon
64
Verizon
VZ
$195B
$172K 0.09%
3,229
CELG
65
DELISTED
Celgene Corp
CELG
$168K 0.09%
1,875
AXP icon
66
American Express
AXP
$227B
$160K 0.08%
1,500
EMR icon
67
Emerson Electric
EMR
$83.9B
$153K 0.08%
2,000
+1,000
+100% +$73.8K
PG icon
68
Procter & Gamble
PG
$336B
$152K 0.08%
1,832
+400
+28% +$32.7K
DE icon
69
Deere & Co
DE
$160B
$150K 0.08%
1,000
TRV icon
70
Travelers Companies
TRV
$78.1B
$149K 0.08%
1,150
AMT icon
71
American Tower
AMT
$80.8B
$145K 0.08%
1,000
DD icon
72
DuPont de Nemours
DD
$18.5B
$143K 0.07%
875
-79
-8% -$13.6K
CLDR
73
DELISTED
Cloudera, Inc.
CLDR
$136K 0.07%
7,700
-5,400
-41% -$82K
BDX icon
74
Becton Dickinson
BDX
$45.6B
$131K 0.07%
513
BMY icon
75
Bristol-Myers Squibb
BMY
$133B
$131K 0.07%
2,105
+250
+13% +$14.8K

Similar funds

Blume Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Blume Capital Management held 206 positions worth $191M, up 4.4% from $183M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Blume Capital Management's Q3 2018 filing shows 11 new, 19 increased, 32 reduced and 5 closed positions. Its largest new stake was Micron Technology: 1,700 shares worth $77K. The largest sale was GSK, an estimated $1.95M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Energy.

  • Blume Capital Management's largest Q3 2018 buy was Micron Technology: 1,700 shares worth $77K.
  • Blume Capital Management added most to Schwab Short-Term US Treasury ETF in Q3 2018, an estimated $2.17M increase.
  • Blume Capital Management's biggest Q3 2018 reduction was GSK, cutting an estimated $1.95M.
  • Blume Capital Management fully exited Chubb in Q3 2018, selling an estimated $51K.
  • Blume Capital Management's ten largest holdings make up 45% of its $191M portfolio in Q3 2018.
  • Blume Capital Management opened 11 new positions and closed 5 in Q3 2018.
  • Blume Capital Management's portfolio value rose 4.4% quarter-over-quarter to $191M.

Based on Blume Capital Management's 13F filing for Q3 2018, filed 2 Nov 2018.